Article Versions Notes

Lin H-S, Huang Y-L, Wang Y-RS, Hsiao E, Hsu T-A, Shiao H-Y, Jiaang W-T, Sampurna BP, Lin K-H, Wu M-S, et al. Identification of Novel Anti-Liver Cancer Small Molecules with Better Therapeutic Index Than Sorafenib via Zebrafish Drug Screening Platform. Cancers. 2019; 11(6):739. https://doi.org/10.3390/cancers11060739

Lin, Han-Syuan, Yi-Luen Huang, Yi-Rui Stefanie Wang, Eugene Hsiao, Tsu-An Hsu, Hui-Yi Shiao, Weir-Torn Jiaang, Bonifasius Putera Sampurna, Kuan-Hao Lin, Ming-Shun Wu, and et al. 2019. "Identification of Novel Anti-Liver Cancer Small Molecules with Better Therapeutic Index Than Sorafenib via Zebrafish Drug Screening Platform" Cancers 11, no. 6: 739. https://doi.org/10.3390/cancers11060739

Lin, H.-S., Huang, Y.-L., Wang, Y.-R. S., Hsiao, E., Hsu, T.-A., Shiao, H.-Y., Jiaang, W.-T., Sampurna, B. P., Lin, K.-H., Wu, M.-S., Lai, G.-M., & Yuh, C.-H. (2019). Identification of Novel Anti-Liver Cancer Small Molecules with Better Therapeutic Index Than Sorafenib via Zebrafish Drug Screening Platform. Cancers, 11(6), 739. https://doi.org/10.3390/cancers11060739